Researcher.Life Logo

Magyar Onkologia : Impact Factor & More

pISSN: 0025-0244

Key Metrics

SJR
Q4Medicine (all)
Recommended pre-submission checks
Powered by Paperpal by Editage

Magyar Onkologia Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • SJR SJR
Overview
Publisher Magyar Onkologusok Tarsasaga

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Check my Paper

Recently Published Papers in Magyar Onkologia

Anna AI - a voluntary AI tool to complement psychosocial care in oncology
  • 12 Mar 2026
  • Magyar onkologia
Prediction of immune checkpoint inhibitor therapy in urothelial carcinoma: integrated analysis of molecular patterns and clinical factors
  • 12 Mar 2026
  • Magyar onkologia
Very accelerated partial breast irradiation (VAPBI) with high-dose-rate interstitial brachytherapy following breast- conserving surgery of low-risk breast cancer patients
  • 12 Mar 2026
  • Magyar onkologia
Could the administration of immune checkpoint inhibitors be discontinued after 2 years of application? Pros and cons for the development of a national guideline.
  • 12 Mar 2026
  • Magyar onkologia
Dosimetric comparison of model-based and conventional calculation algorithms in high-dose-rate brachytherapy of head and neck tumours
  • 12 Mar 2026
  • Magyar onkologia
Rare subtype of kidney cancer - Pigmented microcystic chromophobe carcinoma
  • 12 Mar 2026
  • Magyar onkologia
Anna AI - a voluntary AI tool to complement psychosocial care in oncology
  • 12 Mar 2026
  • Magyar onkologia
Prediction of immune checkpoint inhibitor therapy in urothelial carcinoma: integrated analysis of molecular patterns and clinical factors
  • 12 Mar 2026
  • Magyar onkologia
Very accelerated partial breast irradiation (VAPBI) with high-dose-rate interstitial brachytherapy following breast- conserving surgery of low-risk breast cancer patients
  • 12 Mar 2026
  • Magyar onkologia
Could the administration of immune checkpoint inhibitors be discontinued after 2 years of application? Pros and cons for the development of a national guideline.
  • 12 Mar 2026
  • Magyar onkologia
Dosimetric comparison of model-based and conventional calculation algorithms in high-dose-rate brachytherapy of head and neck tumours
  • 12 Mar 2026
  • Magyar onkologia
Rare subtype of kidney cancer - Pigmented microcystic chromophobe carcinoma
  • 12 Mar 2026
  • Magyar onkologia

FAQs on Magyar Onkologia